The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Intravenous Solutions Market Compare Between 2026 And 2030?
The intravenous solutions market size has witnessed significant expansion in recent years. It is projected to increase from $14.91 billion in 2025 to $16.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be attributed to an increase in hospital admissions and surgical procedures, the widespread application of IV fluids for dehydration management, a rising prevalence of chronic diseases, the established importance of IV therapy in critical care, and the increasing utilization of electrolyte and glucose solutions.
The intravenous solutions market is poised for substantial expansion over the next few years. It is projected to reach $21.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This anticipated growth during the forecast period is driven by the expansion of home healthcare and outpatient infusion services, a growing aging population in need of nutritional support, the increasing adoption of personalized nutrition therapies, advancements in sterile packaging technologies, and a rising demand for long-term parenteral nutrition. Prominent trends throughout this period include an escalating demand for intravenous hydration in both acute and chronic care, the increased utilization of parenteral nutrition in critical and geriatric care, a burgeoning preference for ready-to-use IV solution formulations, the proliferation of home-based IV therapy and infusion services, and an intensified focus on sterility and safety in the manufacturing of IV solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp
What Key Factors Are Shaping The Intravenous Solutions Market Landscape?
The increasing prevalence of cancer is expected to propel the growth of the intravenous solutions market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the ability to invade surrounding tissues and spread to other parts of the body. Intravenous solutions are commonly used in cancer treatment to deliver chemotherapy drugs and maintain hydration during therapy. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the intravenous solutions market.
How Is The Intravenous Solutions Market Broken Down By Segment Categories?
The intravenous solutions market covered in this report is segmented –
1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings
Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions
What Market Trends Are Affecting The Intravenous Solutions Market?
Leading companies in the intravenous solutions market are concentrating on developing innovative syringe types, such as pre-filled and ready-to-administer syringes, to gain a competitive advantage. These syringes come preloaded with medication and are designed for immediate use, eliminating the need for manual filling or preparation. For example, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are crafted from a transparent, durable polymer material, thereby mitigating the risks associated with traditional glass syringes. Their pre-filled and ready-to-administer nature contributes to time efficiency and minimizes medication errors. The rocuronium bromide injection is exclusively for intravenous use. It incorporates several crucial features, including being RFID-enabled with KitCheck, which is the latest kit and tray management technology, intuitive labeling, and a color-coded plunger rod for quick identification.
Which Players Are Present In The Intravenous Solutions Market Space?
Major companies operating in the intravenous solutions market are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.
Get The Full Intravenous Solutions Market Report:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
Which Region Represents The Largest Share Of The Intravenous Solutions Market?
North America was the largest region in the intravenous solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Intravenous Solutions Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
Browse Through More Reports Similar to the Global Intravenous Solutions Market 2026, By The Business Research Company
Intravenous Solutions Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
Empty Intravenous Iv Bags Market Report
https://www.thebusinessresearchcompany.com/report/empty-intravenous-iv-bags-global-market-report
Peripheral Iv Catheters Market Report
https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model